SynthesisFrontiers in pharmacology2023

Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials.

Dingyuan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.